Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
AY.132 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.132 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.132 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.160.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
B.1.160.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.160.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.160.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.160.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.160.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.4.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KF.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KF.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KF.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KF.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CS.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CS.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used